TP53 and neoplasm: These molecular findings may explain the particular ability of chloroquine 3.5 mg/kg to reduce the growth rate and tumor incidence by 41% only in p53-wild-type BALB/c mice exposed to N-methyl-N-nitrosourea after 8 weeks of treatment.